Follow
Marcel A. Müller
Marcel A. Müller
Professor, Institute of Virology, Charité Universitätsmedizin Berlin
Verified email at charite.de
Title
Cited by
Cited by
Year
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor
M Hoffmann, H Kleine-Weber, S Schroeder, N Krüger, T Herrler, ...
cell 181 (2), 271-280. e8, 2020
210162020
Virological assessment of hospitalized patients with COVID-2019
R Wölfel, VM Corman, W Guggemos, M Seilmaier, S Zange, MA Müller, ...
Nature 581 (7809), 465-469, 2020
76892020
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
VS Raj, H Mou, SL Smits, DHW Dekkers, MA Müller, R Dijkman, D Muth, ...
Nature 495 (7440), 251-254, 2013
23522013
Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients
NMA Okba, MA Müller, W Li, C Wang, CH GeurtsvanKessel, VM Corman, ...
Emerging infectious diseases 26 (7), 1478, 2020
16172020
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
J Braun, L Loyal, M Frentsch, D Wendisch, P Georg, F Kurth, ...
Nature 587 (7833), 270-274, 2020
12092020
Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response
I Glowacka, S Bertram, MA Müller, P Allen, E Soilleux, S Pfefferle, I Steffen, ...
Journal of virology 85 (9), 4122-4134, 2011
12082011
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
CBEM Reusken, BL Haagmans, MA Müller, C Gutierrez, GJ Godeke, ...
The Lancet infectious diseases 13 (10), 859-866, 2013
9162013
The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells
M Hoffmann, H Kleine-Weber, N Krüger, M Müller, C Drosten, ...
BioRxiv, 2020.01. 31.929042, 2020
8782020
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
VM Corman, I Eckerle, T Bleicker, A Zaki, O Landt, M Eschbach-Bludau, ...
Eurosurveillance 17 (39), 2012
7462012
Bats host major mammalian paramyxoviruses
JF Drexler, VM Corman, MA Müller, GD Maganga, P Vallo, T Binger, ...
Nature communications 3 (1), 796, 2012
7052012
Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection
C Drosten, M Seilmaier, VM Corman, W Hartmann, G Scheible, S Sack, ...
The Lancet infectious diseases 13 (9), 745-751, 2013
5062013
Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19
M Hoffmann, S Schroeder, H Kleine-Weber, MA Müller, C Drosten, ...
Antimicrobial agents and chemotherapy 64 (6), 10.1128/aac. 00754-20, 2020
4982020
Serological assays for emerging coronaviruses: challenges and pitfalls
B Meyer, C Drosten, MA Müller
Virus research 194, 175-183, 2014
4922014
Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA …
JF Drexler, F Gloza-Rausch, J Glende, VM Corman, D Muth, M Goettsche, ...
Journal of virology 84 (21), 11336-11349, 2010
4672010
Transmission of MERS-coronavirus in household contacts
C Drosten, B Meyer, MA Müller, VM Corman, M Al-Masri, R Hossain, ...
New England Journal of Medicine 371 (9), 828-835, 2014
4622014
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
VM Corman, MA Müller, U Costabel, J Timm, T Binger, B Meyer, P Kreher, ...
Eurosurveillance 17 (49), 20334, 2012
4552012
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors
S Pfefferle, J Schöpf, M Kögl, CC Friedel, MA Müller, J Carbajo-Lozoya, ...
PLoS pathogens 7 (10), e1002331, 2011
4492011
Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection
VM Corman, AM Albarrak, AS Omrani, MM Albarrak, ME Farah, M Almasri, ...
Clinical Infectious Diseases 62 (4), 477-483, 2016
4482016
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
M Hoffmann, K Mösbauer, H Hofmann-Winkler, A Kaul, H Kleine-Weber, ...
Nature 585 (7826), 588-590, 2020
4442020
Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013
ZA Memish, M Cotten, B Meyer, SJ Watson, AJ Alsahafi, AA Al Rabeeah, ...
Emerging infectious diseases 20 (6), 1012, 2014
4382014
The system can't perform the operation now. Try again later.
Articles 1–20